HealthPadTalks

Wearables were dismissed as consumer gadgets. That now looks like a strategic mistake. This episode explores how real-time health data is shifting value from devices to data platforms, and from episodic care to continuous patient management. In MedTech, the future may belong less to those who sell the hardware than to those who understand the patient journey. 

AI is everywhere in healthcare—so why isn’t productivity improving? This episode unpacks the Great Productivity Mirage, revealing how hype outpaces real impact when organizations layer AI onto outdated systems. True gains require more than tools—they demand structural reinvention, bold leadership, and a culture built for continuous learning. The message is clear: AI amplifies what already exists. Without transformation, it scales dysfunction—not performance. 

Healthcare doesn’t have an innovation problem - it has an execution problem.
In this episode, we explore the real bottleneck holding healthcare back: not a lack of breakthroughs, but a system unable to implement them. Too many promising innovations do not fail in the lab - they stall in institutions designed for stability, not speed. In healthcare, value is not created at invention; it is created at implementation - within workflows, across procurement, and through regulation. The next winners will not be those who build more tech, but those who make it work in the real world. If your strategy still relies on innovation theatre, it is already behind.

96% of MedTech leaders believe in connected care—yet many still treat it as an add-on, not a strategic shift.

In this episode, we challenge a core misconception: dashboards aren’t strategies, and connectivity isn’t platform ownership. As care moves into the home, winners will be defined by outcomes and infrastructure—not devices.

We explore how AI and data platforms are reshaping the sector—and what it takes to move beyond products and stay relevant.

If you’re still selling the box, you’re already losing ground.

India is rewriting the healthcare playbook. Fortress hospitals are giving way to asset-light care models centred on specialised clinics, distributed networks, and scalable, high-volume delivery. For Western MedTechs eyeing India, the signal is clear: success will depend less on hospital bed expansion than on modular technologies, flexible pricing, and products built for decentralised care. Those who crack this model will not just win in India - they will help shape the future blueprint of global healthcare. 

Hydrocephalus is shifting from a device market to a multi-billion-dollar neurotechnology platform opportunity. In this episode, we explore the move from failure-prone shunts to adaptive, closed-loop systems integrating smart sensing, biologics, connectivity, and minimally invasive access. The companies that own the system architecture and data loop will define the next era of neurotech. 

90% of drug candidates die before they ever matter - the “Valley of Death.” This episode goes to the failure point most pipelines avoid: Phase-0. We explore how microdosing, ultra-sensitive measurement, and AI-designed molecules turn early clinical insight into human truth - so teams make smarter calls, protect patients, and stop burning capital. 

Medical misinformation isn’t new, but today it scales at speed. This episode tracks the shift from fringe vaccine resistance to algorithm-amplified mythmaking, and how institutional failures turn mistrust into harm. From the UK infected blood scandal to the US opioid crisis, we unpack what broke, and what must change.

Healthcare doesn’t need safer strategies - it needs sharper ones. In this episode, we dismantle the “well-diversified” leadership myth and argue that hedging is a slowdown in an AI, platform-driven world. As value shifts from factories to data, learning speed, and software intelligence, competitive advantage comes from choosing the right complexity - and committing deeply enough for compounding to begin.

In this year-end episode of HealtPadTalks, we dissect the forces redrawing the MedTech landscape - and the blind spots leaders can no longer afford. Hardware is ceding ground to AI-driven, data-intensive platforms that span the full patient journey: always on, always learning, always scaling. The centre of gravity is shifting - and fast. While the US and Europe still command attention, momentum is accelerating in Saudi Arabia, India, and across Africa. New markets. New rules. New power dynamics. This is a wake-up call. The next generation of MedTech winners won’t compete on devices alone, but on intelligence, analytics, and business models built for a global MedTech arms race.